Sage Therapeutics
$72.539876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$72.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.92 (-1.25%) As of 5:09 PM UTC today
Why Robinhood?
You can buy or sell SAGE and other stocks, options, and ETFs commission-free!
About SAGE
Sage Therapeutics, Inc. Common Stock, also called Sage Therapeutics, is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system.
CEO
Barry E. Greene
Employees
298
Headquarters
Cambridge, Massachusetts
Founded
2010
Market Cap
4.26B
Price-Earnings Ratio
6.56
Dividend Yield
—
Average Volume
546.41K
High Today
$74.79
Low Today
$72.17
Open Price
$73.27
Volume
361.50K
52 Week High
$98.39
52 Week Low
$33.08
Analyst Ratings
62%
of 21 ratings
Buy
62%
Hold
38%
Sell
0%
SAGE Earnings
-$3.61
$3.66
$10.92
$18.19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available May 4, Pre-Market